Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.10 and traded as high as $0.15. Enzon Pharmaceuticals shares last traded at $0.15, with a volume of 27,004 shares.
Enzon Pharmaceuticals Stock Down 11.8 %
The stock has a fifty day moving average of $0.11 and a two-hundred day moving average of $0.10.
Enzon Pharmaceuticals (OTCMKTS:ENZN – Get Free Report) last posted its quarterly earnings data on Wednesday, March 20th. The biotechnology company reported $0.01 EPS for the quarter.
Enzon Pharmaceuticals Company Profile
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Recommended Stories
- Five stocks we like better than Enzon Pharmaceuticals
- Insider Trades May Not Tell You What You Think
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- What Investors Need to Know About Upcoming IPOs
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- How to invest in marijuana stocks in 7 steps
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
